Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Activists drew attention to the deadly consequences of the pharmaceutical industry hiking drug prices in a protest on September 14, 2016 in New York City. (Photo: Erik McGregor/LightRocket via Getty Images)

Activists drew attention to the deadly consequences of the pharmaceutical industry hiking drug prices in a protest on September 14, 2016 in New York City. (Photo: Erik McGregor/LightRocket via Getty Images)

"Drugs Don't Work If People Can't Afford Them": Big Pharma to Raise Prices of 300 Medications on Jan. 1

"The increases come as pharmaceutical companies like Pfizer are playing hero by developing vaccines for Covid-19 in record time."

Kenny Stancil

As a result of the coronavirus pandemic, hospitalizations skyrocketed in 2020, but routine visits to the doctor's office and demand for new prescription medications fell sharply during the worldwide lockdown.

To make up for lost revenue, the pharmaceutical industry plans to ring in the New Year by raising prices on more than 300 drugs in the United States on January 1, according to an analysis by healthcare consulting firm 3 Axis Advisors, whose findings were summarized in an exclusive report published Thursday in Reuters.

As Reuters pointed out, "The increases come as pharmaceutical companies like Pfizer are playing hero by developing vaccines for Covid-19 in record time."

While scientific advances made by pharmaceutical companies have contributed to defeating the pandemic, critics argue that it would be naive to assume the industry is simply motivated to improve people's well-being.

"Big Pharma's greed is a danger to public health," Reps. Pramila Jayapal (D-Wash.) and Mark Pocan (D-Wis.) said earlier this year, when Gilead announced that it would charge U.S. hospitals $3,120 per privately insured patient for a treatment course of remdesivir, a Covid-19 drug whose development was financed in large part by taxpayers.

Pfizer spokesperson Amy Rose pointed to the coronavirus vaccine the company developed with Germany's BioNTech in an attempt to justify next year's drug price hikes. "This modest increase," Rose said in a statement, "is necessary to support investments that allow us to continue to discover new medicines and deliver those breakthroughs to the patients who need them."

Nevertheless, as David Mitchell, a cancer patient and founder of Patients for Affordable Drugs Now, said last month, "Drugs don't work if people can't afford them."

To "get innovation we need at prices we can afford," Mitchell added, "restore balance... [and] end unlimited drug corporation pricing power."

Drug manufacturers, including Pfizer, Sanofi USA, and GlaxoSmithKline, "are also fighting new drug price cutting rules from the Trump administration, which would reduce the industry's profitability," Reuters reported.

President Donald Trump pledged in 2016 to reduce prescription drug prices in the U.S., which are among the highest in the world, but it wasn't until late 2020 that he issued a handful of executive orders meant to slash prices. According to Reuters, "Their impact could be limited by legal challenges and other problems."

The news outlet continued:

A federal judge earlier this month blocked a last-minute Trump administration rule aimed at lowering drug prices that was set to be implemented at the beginning of the year. It was challenged by drug industry groups including PhRMA, the nation's leading pharmaceutical trade group.

President-elect [Joe] Biden has also vowed to reduce drug costs and to allow Medicare, a U.S. government health insurance program, to negotiate drug prices. He has support from congressional Democrats to pass such legislation, which the Congressional Budget Office has said could cost the industry more than $300 billion by 2029.

As Common Dreams reported last month, researchers have linked the failure to address the unaffordable costs of prescription medications to a rise in "cost-related nonadherence" to drug therapy, which increases preventable suffering, premature deaths, and healthcare spending. 


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

Indignation as Michigan Judge Drops Flint Water Charges Against GOP Ex-Gov Snyder

"The people of Flint deserve justice—and it's unacceptable that the people responsible for Flint's water crisis aren't being held accountable," said Food & Water Watch in response to the development.

Brett Wilkins ·


70+ Lawmakers Tell Biden 'You Can and You Must' Provide Rail Workers Paid Sick Leave

"As president, you and your administration have a number of tools at your disposal to make sure rail workers are guaranteed paid sick leave," wrote the lawmakers.

Julia Conley ·


COP15 Biodiversity Summit Highlights 'Deadly' US Attitude Toward the World

"While others play by the rules, the most powerful nation refuses," writes George Monbiot. "If this country were a person, we'd call it a psychopath. As it is not a person, we should call it what it is: a rogue state."

Jessica Corbett ·


Final House Covid Panel Report Exposes 'Reckless' Trump Pandemic Response

The publication accuses top Trump officials of "failed stewardship" and a "persistent pattern of political interference" that undermined the nation's response to a pandemic that has killed more than a million people in the United States.

Brett Wilkins ·


As NYT Staffers Strike, Sanders Calls for 'New Ways to Empower' Workers Battling Industry Giants

"We need to rebuild and protect a diverse and truly independent press so that real journalists and media workers can do the critical jobs that they love, and that a functioning democracy requires," said the Vermont progressive.

Kenny Stancil ·

Common Dreams Logo